Evidence map›Paper›PMID 28982545›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2017

Pediatric norovirus GII.4 infections in Nicaragua, 1999-2015.

Filemón Bucardo, Yaoska Reyes, Sylvia Becker-Dreps, Natalie Bowman, Joann F Gruber, Jan Vinjé, Felix Espinoza, Margarita Paniagua, Angel Balmaseda, Lennart Svensson and 1 more

Open access · greenAbstract readHistorical Article
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Filemón BucardoNational Autonomous University of Nicaragua, León, Nicaragua. Electronic address: fili_bucardo@hotmail.com.
Yaoska ReyesNational Autonomous University of Nicaragua, León, Nicaragua.
Sylvia Becker-DrepsSchool of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Natalie BowmanSchool of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Joann F GruberDepartment of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, USA.
Jan VinjéDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Felix EspinozaNational Autonomous University of Nicaragua, León, Nicaragua.
Margarita PaniaguaNational Autonomous University of Nicaragua, León, Nicaragua.
Angel BalmasedaNational Virology Laboratory, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua.
Lennart SvenssonDivision of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Johan NordgrenDivision of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Universidad Nacional Autónoma de Nicaragua-León · NIUniversity of North Carolina at Chapel Hill · USLinköping University · SECenters for Disease Control and Prevention · USNational Autonomous University of Nicaragua · NI

Funding

Preliminary Effectiveness Analysis of Universal Rotavirus Immunization, NicaraguaK01TW008401 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BECKER-DREPS, SYLVIA IRENE · 2009 to 2012
$507k
FIC NIH HHS K01 TW008401Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectivesInvestigate clinical and epidemiological factors of pediatric GII.4 norovirus infections in children with acute gastroenteritis (AGE) in Nicaragua between 1999 and 2015.

methodsWe retrospectively analyzed laboratory and epidemiologic data from 1,790 children≤7years with AGE from 6 hospitals in Nicaragua (n=538), and 3 community clinics (n=919) and households (n=333) in León, between 1999 and 2015. Moreover, asymptomatic children from community clinics (n=162) and households (n=105) were enrolled. Norovirus was detected by real-time PCR and genotyped by sequencing the N-terminal and shell region of the capsid gene.

resultsNorovirus was found in 19% (n=338) and 12% (n=32) of children with and without AGE, respectively. In total, 20 genotypes including a tentatively new genotype were detected. Among children with AGE, the most common genotypes were GII.4 (53%), GII.14 (7%), GII.3 (6%) and GI.3 (6%). In contrast, only one (1.4%) GII.4 was found in asymptomatic children. The prevalence of GII.4 infections was significantly higher in children between 7 and 12months of age. The prevalence of GII.4 was lowest in households (38%), followed by community clinics (50%) and hospitals (75%). Several different GII.4 variants were detected and their emergence followed the global temporal trend.

conclusionsOverall our study found the predominance of pediatric GII.4 norovirus infections in Nicaragua mostly occurring in children between 7 and 12months of age, implicating GII.4 as the main norovirus vaccine target.

Indexed as

NorovirusAdolescentCaliciviridae InfectionsChildChild, PreschoolGastroenteritisGenotypeHistory, 21st CenturyHumansIncidenceInfantInfant, NewbornNicaraguaOdds RatioPublic Health SurveillanceRetrospective StudiesAsymptomaticCommunityGastroenteritisGII.4NicaraguaNorovirusPediatric

Identifiers

PMID28982545
PMCPMC5911913
OpenAlexW2760933195

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.